Abstract:Loss-of-function mutations in the Notch ligand, Jagged1 (Jag1), result in multi-system developmental pathologies associated with Alagille syndrome (ALGS). ALGS patients present with skeletal manifestations including hemi-vertebrae, reduced bone mass, increased fracture incidence and poor bone healing. However, it is not known whether the increased fracture risk is due to altered bone homeostasis (primary) or nutritional malabsorption due to chronic liver disease (secondary). To determine the significance of Jag1 loss in bone, we characterized the skeletal phenotype of two Jag1-floxed conditional knockout mouse models: Prx1-Cre;Jag1(f/f) to target osteoprogenitor cells and their progeny, and Col2.3-Cre;Jag1(f/f) to target mid-stage osteoblasts and their progeny. Knockout phenotypes were compared to wild-type (WT) controls using quantitative micro-computed tomography, gene expression profiling and mechanical testing. Expression of Jag1 and the Notch target genes Hes1 and Hey1 was downregulated in all Jag1 knockout mice. Osteoblast differentiation genes were downregulated in whole bone of both groups, but unchanged in Prx1-Cre;Jag1(f/f) cortical bone. Both knockout lines exhibited changes in femoral trabecular morphology including decreased bone volume fraction and increased trabecular spacing, with males presenting a more severe trabecular osteopenic phenotype. Prx1-Cre;Jag1(f/f) mice showed an increase in marrow mesenchymal progenitor cell number and, counterintuitively, developed increased cortical thickness resulting from periosteal expansion, translating to greater mechanical stiffness and strength. Similar alterations in femoral morphology were observed in mice with canonical Notch signaling disrupted using Prx1-Cre-regulatable dominant-negative mastermind like-protein (dnMAML). Taken together, we report that 1) Jag1 negatively regulates the marrow osteochondral progenitor pool, 2) Jag1 is required for normal trabecular bone formation and 3) Notch signaling through homotypic Jag1 signaling in osteochondral progenitors, but not mature osteoblasts, inhibits periosteal expansion. Therefore, Jag1 signaling within the osteoblast lineage regulates bone metabolism in a compartment-dependent manner. Moreover, loss of Jag1 function in osteoblast lineage cells may contribute to the skeletal phenotype associated with ALGS.

Jagged-mediated development and disease: Mechanistic insights and therapeutic implications for Alagille syndrome

Alagille Syndrome is Caused by Mutations in Human Jagged1, Which Encodes A Ligand for Notch1

Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Endothelial Deletion of Murine Jag1 Leads to Valve Calcification and Congenital Heart Defects Associated with Alagille Syndrome

Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects

Regenerative Failure of Intrahepatic Biliary Cells in Alagille Syndrome Rescued by Elevated Jagged/Notch/Sox9 Signaling

Conditional JAG1 Mutation Shows the Developing Heart is More Sensitive Than Developing Liver to JAG1 Dosage

Jag1 Insufficiency Disrupts Neonatal T Cell Differentiation and Impairs Hepatocyte Maturation, Leading to Altered Liver Fibrosis

Advances in the Research of Molecular Genetics of Alagille Syndrome

[Identification of a Novel JAG1 Mutation in a Family Affected by Alagille Syndrome].

JAG1 Loss‑of‑function Mutations Contributed to Alagille Syndrome in Two Chinese Families.

Mutation Analysis of Jagged1 (JAG1) in Alagille Syndrome Patients Communicated by Ian McIntosh Online Citation: Human Mutation, Mutation in Brief #397 (2000) Online Http://Journals.wiley.com/1059-7794/Pdf/mutation/397.pdf

Intrahepatic cholangiocyte regeneration from an Fgf‐dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome

Jag1 Mutation Spectrum And Origin In Chinese Children With Clinical Features Of Alagille Syndrome

Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice

Analysis of JAG1 Gene Variant in Chinese Patients with Alagille Syndrome.

Case Report: Novel JAG1 Gene Mutations in Two Infants with Alagille Syndrome Characterized by Cholestasis

[Clinical and Genetic Study of an Infant with Alagille Syndrome: Identification of a Novel Chromosomal Interstitial Deletion Including JAG1 Gene].

Jag1 represses Notch activation in lateral supporting cells and inhibits an outer hair cell fate in the medial cochlea

Bleeding in patients and mice with Alagille syndrome: sex differences and risk factors